No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
CareRx Corp. Is Maintained at Buy by Desjardins Securities
CareRx Corp: MDA EN
CareRx Corp: AUDITED ANNUAL FINANCIAL STATEMENTS EN
CareRx Corporation Reports Q4 Adjusted EPS of $0.12, Far Above FactSet Est of $0.02
CareRx Corporation to Host Fourth Quarter 2024 Financial Results Conference Call on Wednesday, March 5, 2025 at 8:30 A.m. ET
CareRx Brief: Final Tranche of Unsecured Convertible Debentures Issued Have Been Converted Into Common Shares at a Price of C$3.00 per Common Share